New Delhi: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age. The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform from Friday evening.
The nasal vaccine — BBV154 — received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose. The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries.
Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged them to wear masks in crowded places, while also directing officials to strengthen surveillance measures, especially at international airports.
Making a statement in the Rajya Sabha, Union Health Minister Mansukh Mandaviya informed about India’s current status and the country’s preparedness to keep the pandemic in check. He urged all the members of Parliament to help spread community awareness about the pandemic and the need to remain alert.
For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest India News on India.com.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts Cookies Policy.